Vanderbilt Eye Institute

Novel therapy eases stress of retinoblastoma treatment

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

Keeping an eye on blast trauma

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

Award highlights Wayman’s resident education efforts

Laura Wayman, M.D., associate professor of Ophthalmology and Visual Sciences, has been awarded the 2014 Straatsma Award for Excellence in Resident Education.

VEI taking novel approach to fight blinding diseases

Personalized medicine — the effort to tailor health care to individual patients’ needs, genetic profiles and circumstances — is a well-established concept at Vanderbilt University Medical Center.

1 6 7 8 9 10 11